Dr. Shaun Gobind Singh Grewal, MD

Dr. Grewal practices at Urologic Specialists of Oklahoma Inc in Tulsa, Oklahoma.

Dr. Grewal's NPI, 1972764496, was assigned on June 18, 2008. Dr. Grewal graduated from OU College of Medicine in 2008. Dr. Grewal holds Oklahoma license 29661.

Dr. Grewal's primary practice is Urologic Specialists of Oklahoma Inc, at 10901 E 48th S St, Tulsa, OK 74146 in Tulsa County. The practice phone is (918) 749-8765.

Dr. Grewal's primary practice is Urologic Specialists of Oklahoma Inc in Tulsa, Oklahoma. Dr. Grewal is also affiliated with Ascension St. John Medical Center. The medical group on file is Mercy Clinic Family Medicine - Hollister. Dmand AI also links Dr. Grewal to 4 more hospitals, 5 group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grewal practices, 10 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Grewal's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Grewal is board certified in urology by the American Board of Urology. Dmand AI has Dr. Grewal's licenses on file in 3 states: Oklahoma, Missouri and Arkansas.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Grewal treats.

CMS data shows 17,186 Medicare services from Dr. Grewal across 41 procedure codes in 2024, for 1,222 Medicare patients. Medicare paid $245,873 for them.

CMS counts 1,222 Medicare patients who saw Dr. Grewal in 2024. The largest group is 65 to 74, with 509 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Grewal's median patient age at 71, with 27% women.

In 2024, Dr. Grewal wrote 2,127 Medicare Part D claims for 531 patients. 87% of them were for generic drugs. CMS names the drug for 2,017 of them, across 32 drugs with 11 or more claims each, at $2,207,779 in total drug cost. In 2023, CMS named 1,921 claims across 31 drugs.

Dr. Grewal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of prostate resection by Dr. Grewal, more than 90% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Grewal, published from 2012 to 2014. 2012 was the busiest year, with 3. The most frequent topics are Anti-Infective Agents, Local, Penile Prosthesis and Prosthesis Implantation. Dr. Grewal has published most often in Urology. Dr. Grewal's most frequent co-authors are Steven Benjamin Brandes, MD and Lawrence Luen Shean Yeung, MD.

CMS Open Payments shows 489 general payments to Dr. Grewal from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,515.

Dr. Grewal graduated from OU College of Medicine in 2008.

Dr. Grewal is in network with 21 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.